general_news

Singapore – – September 12, 2026 -- The Alliance to End Plastic Waste has catalysed US$641 million in third-party and impact-investor funding commitments since 2019, according to its newly released 2025 Progress Report covering the first year of Strategy 2030 implementation.

Cumulative waste reduction reaches 378,147 tonnes since 2019

The organisation reduced 138,162 tonnes of unmanaged plastic waste and valorised 165,317 tonnes in 2025 alone, pushing cumulative totals to 378,147 tonnes reduced and 418,529 tonnes captured for value since inception. Education and behaviour-change programs have reached over 1.5 million people, and the Alliance engaged 559 organisations in 2025 to finance, develop, and implement projects.

Dubai – September 12, 2026 -- Flytxt has won a Bronze Stevie Award in the "Best AI-driven Product" category at the 23rd Annual International Business Awards for its agentic AI platform Niya-X.

Niya-X moves beyond task automation to autonomous decision-making

Unlike AI co-pilots that assist humans or task-oriented agents that automate workflows, Niya-X deploys domain-specific "AI Experts" capable of understanding business goals, formulating strategies, making decisions, coordinating actions and learning continuously from outcomes. The platform relies on causal learning and counterfactual modeling to simulate and evaluate alternative market scenarios before selecting the course of action most likely to achieve a desired result, while operating within defined corporate governance and data-privacy constraints.

Barnard, Vt. – September 13, 2026 -- MIB Agents began accepting letters of intent on September 9 for its 2027 OutSmarting Osteosarcoma research grant cycle, offering a combined $150,000 to fund translational studies on the pediatric bone cancer.

Two grants totaling $150,000 target established and emerging researchers

The 2027 cycle includes a $100,000 Hero Grant and a $50,000 Hope Young Investigator Grant. Since launching in 2017, the program has distributed more than $2.9 million across 37 investigators studying osteosarcoma, an aggressive primary bone cancer diagnosed in roughly 1,000 people annually in the United States, nearly half of them children, adolescents and young adults.

New York – September 13, 2026 -- Cyware is backing a Department of Energy-funded initiative led by the research arm of the National Rural Electric Cooperative Association (NRECA) to expand Operational Technology (OT) monitoring across nearly 900 electric cooperatives nationwide.

NRECA targets standardized threat data across rural utility networks

The project, run under NRECA's ICS-REC program, aims to standardize the collection, correlation and normalization of OT security data from participating rural cooperatives, enabling centralized analysis and faster threat detection across the grid.

Suzhou – September 13, 2026 -- Transcenta Therapeutics has licensed its Highly Intensified Continuous Bioprocessing (HiCB) platform to WuXi Biologics under a non-exclusive technology agreement, securing an upfront payment of RMB 10 million plus future milestone payments.

Transcenta and subsidiary HJB grant WuXi Biologics non-exclusive rights to HiCB and ExcelPro media

Under the deal, Transcenta and its subsidiary HJB will license certain technologies tied to the HiCB continuous bioprocessing platform and its ExcelPro cell culture media to WuXi Biologics and its affiliates. WuXi Biologics will become a strategic CMC development partner supporting molecules across Transcenta's pipeline.

Westminster, Colo. – September 13, 2026 -- Ball Corporation (NYSE: BALL) has appointed Darlene J. Nicosia, CEO of Maker's Pride, and Sherry L. Buck, former CFO of W. L. Gore & Associates, to its board of directors, adding decades of manufacturing, procurement and finance expertise ahead of the company's push for profitable growth.

Nicosia brings 30 years of food and beverage operations experience

Nicosia spent much of her career at The Coca-Cola Company, where she served as President of Canada and Northeast U.S. and Chief Procurement Officer. She began her career at PepsiCo and Kraft Foods Group, and previously chaired the Audit Committee at Foot Locker, Inc. from 2020 to 2025. At Ball, Nicosia will join the Nominating/Corporate Governance Committee and Finance Committee.

Salt Lake City – – September 13, 2026 -- Netcraft now provides digital risk protection to seven of the top 12 U.S. financial institutions after five additional banks selected the firm in 2026, the cybercrime detection company announced. The company also serves nine of the world's top 15 banks.

Netcraft surpasses 4.1 million takedowns for 2026, exceeding its full 2025 total

Netcraft passed 4.1 million takedowns for the year in early September 2026, a figure that already eclipses its entire 2025 output. The company attributes the surge to accelerating new customer growth, rising volumes of AI-driven attacks, and expanded coverage through Preemptive Domain Disruption, Phone Scam Disruption, and enhanced social media protection.

New York – September 13, 2026 -- Eddid Securities USA Inc., a FINRA-registered introducing broker-dealer, has secured FINRA-approved correspondent clearing arrangements with tZERO Group under FINRA Rule 4311, granting its clients regulated access to digital asset securities trading and custody.

Eddid USA gains access to tZERO Securities ATS for eligible digital asset securities

Eddid USA, the U.S. subsidiary of Hong Kong-based Eddid Financial, has entered agreements with tZERO's regulated broker-dealer subsidiaries covering trading, clearing, and custody. As a subscriber to the tZERO Securities ATS, operated by tZERO Securities, LLC, Eddid USA can now facilitate customer trading in eligible securities, including digital asset securities.

Toronto – September 13, 2026 -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) will hold a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14, 2026, at 10:30 a.m. EDT.

Cardiol schedules investor session at Lotte New York Palace Hotel

The session takes place in the Louis Room on the fourth floor of the venue. A live webcast will be available under the Events & Presentations section of the company's investor website.

Company advances Phase III trial for recurrent pericarditis treatment

Cardiol's lead candidate, CardiolRx, is being evaluated in the pivotal Phase III MAVERIC trial (NCT06708299) for recurrent pericarditis, following the completed Phase II MAvERIC-Pilot study (NCT05494788). The U.S. FDA has granted Orphan Drug Designation to CardiolRx for pericarditis, including the recurrent form of the disease.

Dubai – September 12, 2026 -- The Dubai International Financial Centre (DIFC), the largest financial hub in the Middle East, Africa and South Asia region, has confirmed the program for the inaugural Dubai Future Finance Week, running from November 2 to 6, 2026, with more than 850 speakers and over 85 events across 14 stages in the city.

DIFC schedules 12 specialized forums under a single financial-sector platform

The event, themed "Finance Reinvented: Converging Innovation, Strategy and Purpose," is structured around six focus areas: fintech, tokenization, Islamic finance, wealth management, sustainable finance and private capital. Each forum is designed to connect global companies, market operators and regulators around a specific segment of financial-sector transformation.